BioMaxima Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	13	10	16	23	25	26
Market Cap Growth	13.32%	-33.82%	-30.31%	-8.23%	-5.07%	730.84%
Enterprise Value	16	13	18	20	27	28
Last Close Price	2.57	2.16	3.46	5.07	5.20	-
PE Ratio	84.15	83.86	117.49	3.68	11.09	15.00
PS Ratio	0.92	0.85	1.47	0.74	1.44	1.95
PB Ratio	1.17	0.95	1.47	2.03	3.89	6.00
P/TBV Ratio	1.18	0.95	1.48	2.05	3.96	6.18
P/FCF Ratio	237.44	-	-	3.91	-	56.98
P/OCF Ratio	27.16	-	43.25	2.87	-	30.01
EV/Sales Ratio	1.16	1.06	1.64	0.66	1.54	2.08
EV/EBITDA Ratio	13.99	13.04	30.92	2.58	8.06	11.65
EV/EBIT Ratio	51.33	43.63	380.60	2.71	8.91	13.59
EV/FCF Ratio	302.91	-	-	3.48	-	60.91
Debt / Equity Ratio	0.34	0.31	0.27	0.11	0.59	0.63
Debt / EBITDA Ratio	3.25	3.19	4.90	0.16	1.13	1.14
Debt / FCF Ratio	69.44	-	-	0.21	-	5.94
Asset Turnover	-	0.70	0.63	2.11	1.44	1.35
Inventory Turnover	-	2.11	1.96	6.55	3.70	3.52
Quick Ratio	0.71	0.70	0.96	2.13	1.13	0.88
Current Ratio	1.41	1.49	2.19	3.30	1.93	1.94
Return on Equity (ROE)	-	1.14%	1.18%	70.75%	41.74%	43.75%
Return on Assets (ROA)	-	1.07%	0.17%	32.00%	15.57%	12.88%
Return on Invested Capital (ROIC)	2.15%	2.15%	0.39%	63.29%	30.67%	27.85%
Return on Capital Employed (ROCE)	2.30%	2.20%	0.30%	55.00%	30.60%	27.10%
Earnings Yield	1.19%	1.19%	0.85%	27.15%	9.01%	6.67%
FCF Yield	0.42%	-5.40%	-23.95%	25.55%	-4.06%	1.75%
Dividend Yield	-	-	-	2.11%	1.88%	-
Payout Ratio	-	-	357.85%	6.74%	10.71%	-
Buyback Yield / Dilution	-0.01%	2.89%	3.16%	0.52%	-4.45%	-15.05%
Total Shareholder Return	-0.01%	2.89%	3.16%	2.62%	-2.56%	-15.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.